Clinical Utility of Prenatal Whole Exome Sequencing

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 316 participants.

Also called NCT03482141

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 316 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03482141
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03482141. Allocation not applicable; no masking; primary purpose diagnostic. Start 2017-08-01 (actual); primary completion 2022-05-13 (actual). Results posted on 2023-04-14.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Utility of Prenatal Whole Exome Sequencing
Acronym
PWES
Condition
Structural Anomalies
Condition
Cardiac Anomalies
Condition
Central Nervous System Anomalies
Condition
Thorax Anomalies
Condition
Genito-urinary Anomalies
Condition
Gastrointestinal Anomalies
Condition
Skeletal Anomalies
Condition
Multiple Anomalies
Intervention (Device)
Whole Exome Sequencing (WES)
Lead sponsor
University of California, San Francisco (class: other)

Record details

Record id
cardio:ct-nct03482141
Content hash
54db6b4bfb0c8108f896cb99e5adbb62160536361e58e9c43092b4cc82eb941c